General Organization of Export and Import control system Report issue

Government Phase 1

Organization Overview

First Clinical Trial
2020
NCT04382950
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

General Organization of Export and Import control system

Active Ingredients

Drugs in Phase 1 Trials (2)

isotretinoin (Accutane) (1 trial)

rbace2 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 1)

Lung Injury (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2